
Ayble Health is the country's most clinically-validated virtual clinic for chronic digestive and autoimmune conditions. Nominated for the 2026 Galien Prize and named to TIME's 2024 Best Solutions for GI list, Ayble's award-winning care model offers unlimited access to a specialized, multidisciplinary care team, a suite of AI-powered precision tools, and curated wellness support, all designed to drive sustainable symptom improvement for patients across the entire acuity spectrum. Ayble is backed by 16 peer-reviewed publications and independently evaluated by the Peterson Health Technology Institute and the Validation Institute. Ayble works with leading employers, health insurance plans, health systems, and community GI practices to scale access to multidisciplinary care, reduce healthcare costs, and improve the lives of millions of Americans with chronic digestive diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/17/26 | $16,000,000 | Series A |
Accomplice Cleveland Clinic Innovations DigiTx Partners M13 Neon Fund ![]() Unum Business Ventures Upfront Ventures | undisclosed |